Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inhibrx Biosciences (INBX) Receivables - Other: 2023-2024

Historic Receivables - Other for Inhibrx Biosciences (INBX) over the last 2 years, with Dec 2024 value amounting to $41,000.

  • Inhibrx Biosciences' Receivables - Other was N/A to $727,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $727,000, marking a year-over-year change of. This contributed to the annual value of $41,000 for FY2024, which is 93.25% down from last year.
  • As of FY2024, Inhibrx Biosciences' Receivables - Other stood at $41,000, which was down 93.25% from $607,000 recorded in FY2023.
  • Over the past 5 years, Inhibrx Biosciences' Receivables - Other peaked at $607,000 during FY2023, and registered a low of $41,000 during FY2024.
  • In the last 2 years, Inhibrx Biosciences' Receivables - Other had a median value of $324,000 in 2023 and averaged $324,000.
  • Data for Inhibrx Biosciences' Receivables - Other shows a maximum YoY crashed of 93.25% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Inhibrx Biosciences' Receivables - Other stood at $607,000 in 2023, then plummeted by 93.25% to $41,000 in 2024.